Feasibility of Transcutaneous Spinal Stimulation in Rehabilitation
A legfontosabb adatok
- Ki végzi
- Janelle Unger
- Hol
- London (Kanada)A helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 15 fő, tervezett
- Kezdés
- 2026. nov. 1.
- Várható befejezés
- 2027. márc. 30.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Transcutaneous Spinal Stimulation
- Inpatient SCI Physiotherapy
- Inpatient SCI Occupational Therapy
- FES Cycling
- A regiszteradat frissítve
- 2026. október 27.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a spinal cord injury (SCI) in rehabilitation at Parkwood Institute. Participants get skin-surface spinal stimulation (TSS) during their usual therapy.
- Életkor
- 18 Years and older
- Nem
- All sexes
- A betegség stádiuma
- Spinal cord injury, complete or incomplete. Symptoms must not be getting steadily worse.
- Korábbi kezelés
- People must be in the FES-Cycling program at Parkwood Institute for at least 6 weeks, or admitted to its In-Patient SCI Rehabilitation program. The record lists Botox to the arms or legs in the last three months as an exclusion, but its wording is unclear.
A részvétel fő kizáró okai
- Another condition that seriously limits active rehabilitation, such as uncontrolled low blood pressure on standing, high fracture risk, or inability to follow directions
- Reasons TSS cannot be used, such as poor skin on the back, a metal implant along the spine, a pacemaker, an active fracture, pregnancy, or uncontrolled epilepsy
- Cancer of the spine or near a stimulation area, or uncontrolled autonomic dysreflexia (sudden dangerous rise in blood pressure)
- Allergy to adhesives
- Not able to communicate and give consent in English
A regiszter feltételei, szó szerint
Mind a 9 feltétel megnézéseKevesebb
Ki vehet részt
- Diagnosis of SCI
- Enrolled in either the FES-Cycling program at Parkwood Institute for at least 6 weeks, or admitted to the In-Patient SCI Rehabilitation program at Parkwood Institute
- Be able to communicate and provide informed consent in English
Ki nem vehet részt
- Have a secondary condition significantly impacting their ability to participate in active rehabilitation (e.g., uncontrolled orthostatic hypotension, high fracture risk, inability to follow directions, etc.)
- Clinical team determines that the person has contraindications to using TSS (i.e., poor skin integrity on their back, implanted metal device along their spine, pacemaker, active fracture, pregnancy, cancer of the spine or adjacent to a stimulation area, uncontrolled epilepsy, uncontrolled autonomic dysreflexia)
- Have an allergy to adhesives
- Experiencing progressive worsening of symptoms related to their SCI
- Have not had Botox to upper or lower extremities in the last three months
- Are not currently participating in another clinical trial with similar objectives
Helyszínek itt: Kanada
- Parkwood Institute Main BuildingLondon, KanadaContact: Jeff Weiler, Gray Centre Manager, PhDToborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
Transcutaneous spinal stimulation (TSS) is a non-invasive neuromodulation approach that delivers electrical stimulation to spinal nerve roots through electrodes placed over the spinal cord. TSS may support motor and functional recovery following spinal cord injury (SCI). However, therapeutic potential alone does not establish whether TSS can be feasibly integrated into routine rehabilitation. Clinical implementation introduces practical considerations including clinician training, device setup and operation, time, safety monitoring, acceptability, organizational resources, and compatibility with existing rehabilitation workflows.
A teljes eredeti leírásKevesebb
This study will evaluate the feasibility of integrating TSS into two existing SCI rehabilitation programs at Parkwood Institute: outpatient upper- and lower-extremity functional electrical stimulation (FES) cycling using the Xcite system with TSS functionality, and routine inpatient physiotherapy and occupational therapy using the Stim2Go device. Evaluating TSS across two rehabilitation contexts will identify setting-specific barriers, facilitators, and implementation requirements.
The primary objective is to evaluate the feasibility, safety, acceptability, and implementation strategies required to integrate TSS into outpatient FES cycling and inpatient SCI rehabilitation. Secondary objectives are to explore preliminary changes in clinical and functional outcomes and synthesize implementation findings into evidence-informed recommendations for TSS implementation.
A multi-methods, multi-intervention case series design will be used. Implementation will be guided by the Active Implementation Frameworks and a Training and Coaching Model. Feasibility will be evaluated using Bowen et al.'s Feasibility Framework and the Theoretical Framework of Acceptability, examining acceptability, demand, implementation, practicality, integration, and limited efficacy.
The study will recruit 15 adults with SCI and up to 10 clinicians. Ten patient participants will be recruited from the outpatient FES cycling program and five from inpatient SCI rehabilitation. Up to 10 clinicians who integrate TSS into participant care will also be recruited.
Outpatient participants will receive TSS during their regularly scheduled FES cycling sessions for four weeks. TSS will be delivered during routine 30-45-minute cycling sessions one to two times per week, targeting the cervical spine for upper-extremity cycling and lower thoracic/lumbar spine for lower-extremity cycling. Inpatient participants will receive TSS using Stim2Go during routine physiotherapy and occupational therapy for a minimum of four weeks, with a target of at least three TSS-assisted sessions per week. TSS will be embedded within usual rehabilitation activities, including transfer training, pre-gait and mobility training, activity-based therapy, and upper-extremity task-specific training.
Primary feasibility outcomes will include recruitment, attrition, intervention adherence, adverse events, and patient and clinician experiences. Following the implementation period, patient participants will complete an acceptability survey and semi-structured interview. Clinicians will complete an acceptability survey and participate in a focus group exploring feasibility, acceptability, barriers, facilitators, and lessons learned from integrating TSS into practice.
Exploratory clinical outcomes will also be examined. For outpatient participants, FES cycling outcomes from the four weeks before TSS will be compared descriptively with the four-week TSS period, including session time, distance, asymmetry, time without motor support, energy, power, crank velocity, and stimulation parameters. For inpatient participants, baseline and post-intervention outcomes will assess standing, walking, balance, mobility, endurance, upper- and lower-extremity strength, upper-extremity function when relevant, and independence in daily activities.
Quantitative feasibility, demographic, survey, cycling, and clinical data will be summarized descriptively and visually. Individual changes in inpatient clinical outcomes will be interpreted using minimal detectable change values where available. Qualitative interview and focus group data will undergo codebook thematic analysis informed by interpretive description to identify implementation experiences, barriers, facilitators, and recommendations.
This study will provide real-world evidence on whether and how TSS can be safely and feasibly incorporated into existing SCI rehabilitation services. Evaluating two devices across inpatient and outpatient contexts will identify practical implementation supports and setting-specific considerations not captured in laboratory-based research. Findings will inform recommendations to support adoption and sustained use of TSS across SCI rehabilitation settings in Canada.
A vizsgálat 2 csoportja
- TSS-Augmented Inpatient SCI Rehabilitation GroupA vizsgált kezelés
Participants (n=5) will receive transcutaneous spinal stimulation (TSS) using the Stim2Go device during routine inpatient physiotherapy (PT) and occupational therapy (OT) for a minimum of 4 weeks. Participants typically receive approximately 10 rehabilitation sessions/week (5 PT and 5 OT), lasting 45-90 minutes. TSS will be embedded within usual rehabilitation without altering its intensity or structure, with a target of at least 3 TSS-assisted sessions/week and additional sessions based on tolerance. TSS will be incorporated into clinically appropriate activities such as transfer, pre-gait and mobility, activity-based, and upper-extremity task-specific training. PTs and OTs will individualize stimulation parameters within a biphasic waveform, 1000 μs pulse duration, 30-35 Hz frequency, and up to 100 mA amplitude. Parameters will be documented for each session.
Kezelés: Transcutaneous Spinal Stimulation, Inpatient SCI Physiotherapy és Inpatient SCI Occupational Therapy
- TSS-Augmented Outpatient FES Cycling ProgramA vizsgált kezelés
Participants (n=10; 5 upper- and 5 lower-extremity riders) will be recruited from Parkwood Institute's outpatient FES Cycling Program. During the 4-week intervention, transcutaneous spinal stimulation (TSS) will be added to participants' usual FES cycling using the Xcite system with TSS functionality and RTI 300 cycle ergometers. Participants will receive TSS during routine 30-45-minute FES cycling sessions, 1-2 times/week. TSS will be applied over the cervical spine (C2-T1) during upper-extremity cycling and lower thoracic/lumbar spine (T12-L5) during lower-extremity cycling. Stimulation will use a biphasic waveform, 1000 μs pulse duration, 30-35 Hz frequency, and up to 100 mA amplitude. Trained clinical leads will oversee TSS delivery and clinician training. Participants will otherwise continue their usual individualized FES cycling program.
Kezelés: Transcutaneous Spinal Stimulation és FES Cycling
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Exploring the Feasibility of Integrating Transcutaneous Spinal Stimulation Into Inpatient and Outpatient Rehabilitation
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. október 27.